
Journal Menu
► ▼ Journal Menu-
- Cancers Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
7 March 2023
Displaying Co-Authors’ Email Addresses on the Webpage of Published Papers
MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page.
We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.
7 March 2023
Cancers | Top 10 Cited Papers in 2022 in the Section “Cancer Causes, Screening and Diagnosis”
1. “Breast Tumour Classification Using Ultrasound Elastography with Machine Learning: A Systematic Scoping Review”
by Ye-Jiao Mao, Hyo-Jung Lim, Ming Ni, Wai-Hin Yan, Duo Wai-Chi Wong and James Chung-Wai Cheung
Cancers 2022, 14(2), 367; https://doi.org/10.3390/cancers14020367
Available online: https://www.mdpi.com/2072-6694/14/2/367
2. “CT-Based Radiomics Analysis to Predict Histopathological Outcomes Following Liver Resection in Colorectal Liver Metastases”
by Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Federica De Muzio, Federica Dell’ Aversana, Carmen Cutolo, Lorenzo Faggioni, Vittorio Miele, Francesco Izzo and Antonella Petrillo
Cancers 2022, 14(7), 1648; https://doi.org/10.3390/cancers14071648
Available online: https://www.mdpi.com/2072-6694/14/7/1648
3. “Contrast MR-Based Radiomics and Machine Learning Analysis to Assess Clinical Outcomes following Liver Resection in Colorectal Liver Metastases: A Preliminary Study”
by Vincenza Granata, Roberta Fusco, Federica De Muzio, Carmen Cutolo, Sergio Venanzio Setola, Federica dell’ Aversana, Alessandro Ottaiano, Antonio Avallone, Guglielmo Nasti, Francesca Grassi et al.
Cancers 2022, 14(5), 1110; https://doi.org/10.3390/cancers14051110
Available online: https://www.mdpi.com/2072-6694/14/5/1110
4. “Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers”
by Alicia Cristina Peña-Romero and Esteban Orenes-Piñero
Cancers 2022, 14(7), 1681; https://doi.org/10.3390/cancers14071681
Available online: https://www.mdpi.com/2072-6694/14/7/1681
5. “Advanced Magnetic Resonance Imaging (MRI) Techniques: Technical Principles and Applications in Nanomedicine”
by Federico Bruno, Vincenza Granata, Flavia Cobianchi Bellisari, Ferruccio Sgalambro, Emanuele Tommasino, Pierpaolo Palumbo, Francesco Arrigoni, Diletta Cozzi, Francesca Grassi, Maria Chiara Brunese et al.
Cancers 2022, 14(7), 1626; https://doi.org/10.3390/cancers14071626
Available online: https://www.mdpi.com/2072-6694/14/7/1626
6. “Radiolabeled Antibodies for Cancer Imaging and Therapy”
by Sagun Parakh, Sze Ting Lee, Hui K. Gan and Andrew M. Scott
Cancers 2022, 14(6), 1454; https://doi.org/10.3390/cancers14061454
Available online: https://www.mdpi.com/2072-6694/14/6/1454
7. “What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review”
by Jules Tianyu Zhang-Yin, Antoine Girard and Marc Bertaux
Cancers 2022, 14(4), 879; https://doi.org/10.3390/cancers14040879
Available online: https://www.mdpi.com/2072-6694/14/4/879
8. “Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer”
by Maria Teresa Masucci, Michele Minopoli, Gioconda Di Carluccio, Maria Letizia Motti and Maria Vincenza Carriero
Cancers 2022, 14(3), 498; https://doi.org/10.3390/cancers14030498
Available online: https://www.mdpi.com/2072-6694/14/3/498
9. “The Practicality of the Use of Liquid Biopsy in Early Diagnosis and Treatment Monitoring of Oral Cancer in Resource-Limited Settings”
by Henry Ademola Adeola, Ibrahim O. Bello, Raphael Taiwo Aruleba, Ngiambudulu M. Francisco, Tayo Alex Adekiya, Anthonio Oladele Adefuye, Paul Chukwudi Ikwegbue and Fungai Musaigwa
Cancers 2022, 14(5), 1139; https://doi.org/10.3390/cancers14051139
Available online: https://www.mdpi.com/2072-6694/14/5/1139
10. “Effect of 5-Aminolevulinic Acid and Sodium Fluorescein on the Extent of Resection in High-Grade Gliomas and Brain Metastasis”
by Lasse Cramer Ahrens, Mathias Green Krabbenhøft, Rasmus Würgler Hansen, Nikola Mikic, Christian Bonde Pedersen, Frantz Rom Poulsen and Anders Rosendal Korshoej
Cancers 2022, 14(3), 617; https://doi.org/10.3390/cancers14030617
Available online: https://www.mdpi.com/2072-6694/14/3/617
7 March 2023
Cancers | Top 10 Cited Papers in 2022 in the Section “Infectious Agents and Cancer”
1. “Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy”
by Jerzy Jaroszewicz, Justyna Kowalska, Małgorzata Pawłowska, Magdalena Rogalska, Dorota Zarębska-Michaluk, Marta Rorat, Beata Lorenc, Piotr Czupryna, Katarzyna Sikorska, Anna Piekarska et al.
Cancers 2022, 14(19), 4720; https://doi.org/10.3390/cancers14194720
Available online: https://www.mdpi.com/2072-6694/14/19/4720
2. “Hospital-Treated Infections and Increased Risk of Two EBV-Related Malignancies: A Nested Case-Control Study”
by Yanping Yang, Li Yin, Qianwei Liu, Jiangwei Sun, Hans-Olov Adami, Weimin Ye, Zhe Zhang and Fang Fang
Cancers 2022, 14(15), 3804; https://doi.org/10.3390/cancers14153804
Available online: https://www.mdpi.com/2072-6694/14/15/3804
3. “Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination”
by Lorenz Schubert, Maximilian Koblischke, Lisa Schneider, Edit Porpaczy, Florian Winkler, Ulrich Jaeger, Stephan Blüml, Helmuth Haslacher, Heinz Burgmann, Judith H. Aberle et al.
Cancers 2022, 14(8), 1962; https://doi.org/10.3390/cancers14081962
Available online: https://www.mdpi.com/2072-6694/14/8/1962
4. “Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis”
by Jina Kim, Hwa Kyung Byun, Tae Hyung Kim, Sun Il Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim and Jinsil Seong
Cancers 2022, 14(10), 2396; https://doi.org/10.3390/cancers14102396
Available online: https://www.mdpi.com/2072-6694/14/10/2396
5. “Distribution of HPV Subtypes in Diverse Anogenital and Oral Samples from Women and Correlation of Infections with Neoplasia of the Cervix”
by Karen Bräutigam, Stefanie Meier, Sabina Meneder, Louisa Proppe, Katharina Stroschein, Stephan Polack, Frank Köster, Achim Rody and Sascha Baum
Cancers 2022, 14(13), 3136; https://doi.org/10.3390/cancers14133136
Available online: https://www.mdpi.com/2072-6694/14/13/3136
6. “HBV preS Mutations Promote Hepatocarcinogenesis by Inducing Endoplasmic Reticulum Stress and Upregulating Inflammatory Signaling”
by Wenbin Liu, Shiliang Cai, Rui Pu, Zixiong Li, Donghong Liu, Xinyu Zhou, Jianhua Yin, Xi Chen, Liping Chen, Jianfeng Wu et al.
Cancers 2022, 14(13), 3274; https://doi.org/10.3390/cancers14133274
Available online: https://www.mdpi.com/2072-6694/14/13/3274
7. “Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis”
by Evgenii Shumilov, Lena Aperdannier, Nicole Schmidt, Christoph Szuszies, Albrecht Neesse, Petra Hoffknecht, Cyrus Khandanpour, Jan-Henrik Mikesch, Matthias Stelljes, Göran Ramin Boeckel et al.
Cancers 2022, 14(15), 3746; https://doi.org/10.3390/cancers14153746
Available online: https://www.mdpi.com/2072-6694/14/15/3746
8. “Intestinal Klebsiella pneumoniae Contributes to Pneumonia by Synthesizing Glutamine in Multiple Myeloma”
by Yihui Wang, Qin Yang, Yinghong Zhu, Xingxing Jian, Jiaojiao Guo, Jingyu Zhang, Chunmei Kuang, Xiangling Feng, Gang An, Lugui Qiu et al.
Cancers 2022, 14(17), 4188; https://doi.org/10.3390/cancers14174188
Available online: https://www.mdpi.com/2072-6694/14/17/4188
9. “Oncogenic and Stemness Signatures of the High-Risk HCMV Strains in Breast Cancer Progression”
by Ranim El Baba, Sébastien Pasquereau, Sandy Haidar Ahmad, Mona Diab-Assaf and Georges Herbein
Cancers 2022, 14(17), 4271; https://doi.org/10.3390/cancers14174271
Available online: https://www.mdpi.com/2072-6694/14/17/4271
10. “2-Deoxyglucose, an Inhibitor of Glycolysis, Enhances the Oncolytic Effect of Coxsackievirus”
by Pavel O. Vorobyev, Dmitry V. Kochetkov, Peter M. Chumakov, Natalia F. Zakirova, Sofia I. Zotova-Nefedorova, Konstantin V. Vasilenko, Olga N. Alekseeva, Sergey N. Kochetkov, Birke Bartosch, Anastasiya V. Lipatova et al.
Cancers 2022, 14(22), 5611; https://doi.org/10.3390/cancers14225611
Available online: https://www.mdpi.com/2072-6694/14/22/5611
7 March 2023
Cancers | Top 10 Cited Papers in 2022 in the Section “Methods and Technologies Development”
1. “The Functional Role of Extracellular Matrix Proteins in Cancer”
by Nadezhda V. Popova and Manfred Jücker
Cancers 2022, 14(1), 238; https://doi.org/10.3390/cancers14010238
Available online: https://www.mdpi.com/2072-6694/14/1/238
2. “Recent Advances of Deep Learning for Computational Histopathology: Principles and Applications”
by Yawen Wu, Michael Cheng, Shuo Huang, Zongxiang Pei, Yingli Zuo, Jianxin Liu, Kai Yang, Qi Zhu, Jie Zhang, Honghai Hong et al.
Cancers 2022, 14(5), 1199; https://doi.org/10.3390/cancers14051199
Available online: https://www.mdpi.com/2072-6694/14/5/1199
3. “Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine”
by Ellen S. Smith, Eric Whitty, Byunghee Yoo, Anna Moore, Lorenzo F. Sempere and Zdravka Medarova
Cancers 2022, 14(6), 1588; https://doi.org/10.3390/cancers14061588
Available online: https://www.mdpi.com/2072-6694/14/6/1588
4. “Validation in an Independent Cohort of MiR-122, MiR-1271, and MiR-15b as Urinary Biomarkers for the Potential Early Diagnosis of Clear Cell Renal Cell Carcinoma”
by Giovanni Cochetti, Luigi Cari, Vincenza Maulà, Rosy Cagnani, Alessio Paladini, Michele Del Zingaro, Giuseppe Nocentini and Ettore Mearini
Cancers 2022, 14(5), 1112; https://doi.org/10.3390/cancers14051112
Available online: https://www.mdpi.com/2072-6694/14/5/1112
5. “A Deep Learning Model for Cervical Cancer Screening on Liquid-Based Cytology Specimens in Whole Slide Images”
by Fahdi Kanavati, Naoki Hirose, Takahiro Ishii, Ayaka Fukuda, Shin Ichihara and Masayuki Tsuneki
Cancers 2022, 14(5), 1159; https://doi.org/10.3390/cancers14051159
Available online: https://www.mdpi.com/2072-6694/14/5/1159
6. “Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases”
by Valentina Giannini, Laura Pusceddu, Arianna Defeudis, Giulia Nicoletti, Giovanni Cappello, Simone Mazzetti, Andrea Sartore-Bianchi, Salvatore Siena, Angelo Vanzulli, Francesco Rizzett et al.
Cancers 2022, 14(1), 241; https://doi.org/10.3390/cancers14010241
Available online: https://www.mdpi.com/2072-6694/14/1/241
7. “Cancer-on-a-Chip: Models for Studying Metastasis”
by Xiaojun Zhang, Mazharul Karim, Md Mahedi Hasan, Jacob Hooper, Riajul Wahab, Sourav Roy and Taslim A. Al-Hilal
Cancers 2022, 14(3), 648; https://doi.org/10.3390/cancers14030648
Available online: https://www.mdpi.com/2072-6694/14/3/648
8. “Colorectal Cancer Diagnosis: The Obstacles We Face in Determining a Non-Invasive Test and Current Advances in Biomarker Detection”
by Faddy Kamel, Khadiga Eltarhoni, Pasha Nisar and Mikhail Soloviev
Cancers 2022, 14(8), 1889; https://doi.org/10.3390/cancers14081889
Available online: https://www.mdpi.com/2072-6694/14/8/1889
9. “Targeting Wnt/β;-Catenin Signaling by TET1/FOXO4 Inhibits Metastatic Spreading and Self-Renewal of Cancer Stem Cells in Gastric Cancer”
by Jingjing Qi, Di Cui, Qi-Nian Wu, Qi Zhao, Zhan-Hong Chen, Lianjie Li, Walter Birchmeier, Yong Yu and Ran Tao
Cancers 2022, 14(13), 3232; https://doi.org/10.3390/cancers14133232
Available online: https://www.mdpi.com/2072-6694/14/13/3232
10. “The Antitumor Effect of Caffeic Acid Phenethyl Ester by Downregulating Mucosa-Associated Lymphoid Tissue 1 via AR/p53/NF-κB Signaling in Prostate Carcinoma Cells”
by Kang-Shuo Chang, Ke-Hung Tsui, Shu-Yuan Hsu, Hsin-Ching Sung, Yu-Hsiang Lin, Chen-Pang Hou, Pei-Shan Yang, Chien-Lun Chen, Tsui-Hsia Feng and Horng-Heng Juang
Cancers 2022, 14(2), 274; https://doi.org/10.3390/cancers14020274
Available online: https://www.mdpi.com/2072-6694/14/2/274
6 March 2023
Cancers | Top 10 Cited Papers in 2022 in the Section "Transplant Oncology and Cancer Nursing Care"
1. “Cannabidiol (CBD) in Cancer Management”
by Kylie O’Brien
Cancers 2022, 14(4), 885; https://doi.org/10.3390/cancers14040885
Available online: https://www.mdpi.com/2072-6694/14/4/885
2. “Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells”
by Timothy Crook, Robert Leonard, Kefah Mokbel, Alastair Thompson, Michael Michell, Raymond Page, Ashok Vaid, Ravi Mehrotra, Anantbhushan Ranade, Sewanti Limaye et al.
Cancers 2022, 14(14), 3341; https://doi.org/10.3390/cancers14143341
Available online: https://www.mdpi.com/2072-6694/14/14/3341
3. “Timely Palliative Care: Personalizing the Process of Referral”
by David Hui, Yvonne Heung and Eduardo Bruera
Cancers 2022, 14(4), 1047; https://doi.org/10.3390/cancers14041047
Available online: https://www.mdpi.com/2072-6694/14/4/1047
4. “Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?”
by Saikat Mitra, Mashia Subha Lami, Avoy Ghosh, Rajib Das, Trina Ekawati Tallei, Fatimawali, Fahadul Islam, Kuldeep Dhama, M. Yasmin Begum, Afaf Aldahish et al.
Cancers 2022, 14(3), 759; https://doi.org/10.3390/cancers14030759
Available online: https://www.mdpi.com/2072-6694/14/3/759
5. “Sex Differences in the Effect of Vitamin D on Fatigue in Palliative Cancer Care—A Post Hoc Analysis of the Randomized, Controlled Trial ‘Palliative-D’”
by Caritha Klasson, Maria Helde Frankling, Anna Warnqvist, Carina Sandberg, Marie Nordström, Carina Lundh-Hagelin and Linda Björkhem-Bergman
Cancers 2022, 14(3), 746; https://doi.org/10.3390/cancers14030746
Available online: https://www.mdpi.com/2072-6694/14/3/746
6. “Physical Exercise Restrains Cancer Progression through Muscle-Derived Factors”
by Argyro Papadopetraki, Maria Maridaki, Flora Zagouri, Meletios-Athanasios Dimopoulos, Michael Koutsilieris and Anastassios Philippou
Cancers 2022, 14(8), 1892; https://doi.org/10.3390/cancers14081892
Available online: https://www.mdpi.com/2072-6694/14/8/1892
7. “Physical Activity as the Best Supportive Care in Cancer: The Clinician’s and the Researcher’s Perspectives”
by Cécile Torregrosa, Frédéric Chorin, Eva Ester Molina Beltran, Cindy Neuzillet and Victoire Cardot-Ruffino
Cancers 2022, 14(21), 5402; https://doi.org/10.3390/cancers14215402
Available online: https://www.mdpi.com/2072-6694/14/21/5402
8. “Sinonasal Inverted Papilloma and Squamous Cell Carcinoma: Contemporary Management and Patient Outcomes”
by Jacob G. Eide, Kevin C. Welch, Nithin D. Adappa, James N. Palmer and Charles C. L. Tong
Cancers 2022, 14(9), 2195; https://doi.org/10.3390/cancers14092195
Available online: https://www.mdpi.com/2072-6694/14/9/2195
9. “Supportive Care Needs Assessment for Cancer Survivors at a Comprehensive Cancer Center in the Middle East: Mending the Gap”
by Amal Al-Omari, Nedal Al-Rawashdeh, Rana Damsees, Khawlah Ammar, Ibrahim Alananzeh, Bayan Inserat, Dalia Al-Rimawi, Shrouq Tbayshat, Hazim Ababneh, Haneen Alishreim et al.
Cancers 2022, 14(4), 1002; https://doi.org/10.3390/cancers14041002
Available online: https://www.mdpi.com/2072-6694/14/4/1002
10. “Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer”
by Karel C. Smit, Jeroen W. G. Derksen, Geerard L. O. Beets, Eric J. Th. Belt, Maaike Berbée, Peter Paul L. O. Coene, Hester van Cruijsen, Marjan A. Davidis, Jan Willem T. Dekker, Joyce M. van Dodewaard-de Jong et al.
Cancers 2022, 14(4), 1001; https://doi.org/10.3390/cancers14041001
Available online: https://www.mdpi.com/2072-6694/14/4/1001
1 March 2023
Cancers | Top 10 Cited Papers in 2022 in the Section “Cancer Immunology and Immunotherapy”
1. “Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis”
by Alessandro Rizzo, Antonio Cusmai, Francesco Giovannelli, Silvana Acquafredda, Lucia Rinaldi, Andrea Misino, Elisabetta Sara Montagna, Valentina Ungaro, Mariagrazia Lorusso and Gennaro Palmiotti
Cancers 2022, 14(6), 1404; https://doi.org/10.3390/cancers14061404
Available online: https://www.mdpi.com/2072-6694/14/6/1404
2. “The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions”
by Tadeusz Robak, Magda Witkowska and Piotr Smolewski
Cancers 2022, 14(3), 771; https://doi.org/10.3390/cancers14030771
Available online: https://www.mdpi.com/2072-6694/14/3/771
3. “The Good, the Bad, and the Ugly: Neutrophils, Angiogenesis, and Cancer”
by Irem Ozel, Inga Duerig, Maksim Domnich, Stephan Lang, Ekaterina Pylaeva and Jadwiga Jablonska
Cancers 2022, 14(3), 536; https://doi.org/10.3390/cancers14030536
Available online: https://www.mdpi.com/2072-6694/14/3/536
4. “Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study”
by Beom Kyung Kim, Jaekyung Cheon, Hyeyeong Kim, Beodeul Kang, Yeonjung Ha, Do Young Kim, Seong Gyu Hwang, Young Eun Chon and Hong Jae Chon
Cancers 2022, 14(7), 1747; https://doi.org/10.3390/cancers14071747
Available online: https://www.mdpi.com/2072-6694/14/7/1747
5. “Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer”
by Ching-Hung Hsieh, Cheng-Zhe Jian, Liang-In Lin, Guan-Sian Low, Ping-Yun Ou, Chiun Hsu and Da-Liang Ou
Cancers 2022, 14(2), 294; https://doi.org/10.3390/cancers14020294
Available online: https://www.mdpi.com/2072-6694/14/2/294
6. “Clinical Significance of the Duality of Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma”
by Tomoko Aoki, Naoshi Nishida and Masatoshi Kudo
Cancers 2022, 14(2), 444; https://doi.org/10.3390/cancers14020444
Available online: https://www.mdpi.com/2072-6694/14/2/444
7. “Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review”
by Biagio Barone, Armando Calogero, Luca Scafuri, Matteo Ferro, Giuseppe Lucarelli, Erika Di Zazzo, Enrico Sicignano, Alfonso Falcone, Lorenzo Romano, Luigi De Luca et al.
Cancers 2022, 14(10), 2545; https://doi.org/10.3390/cancers14102545
Available online: https://www.mdpi.com/2072-6694/14/10/2545
8. “Biomarkers of Response and Resistance to Immunotherapy in Microsatellite Stable Colorectal Cancer: Toward a New Personalized Medicine”
by Nicolas Huyghe, Elena Benidovskaya, Philippe Stevens and Marc Van den Eynde
Cancers 2022, 14(9), 2241; https://doi.org/10.3390/cancers14092241
Available online: https://www.mdpi.com/2072-6694/14/9/2241
9. “Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes”
by Alessandro Di Federico, Mirta Mosca, Rachele Pagani, Riccardo Carloni, Giorgio Frega, Andrea De Giglio, Alessandro Rizzo, Dalia Ricci, Simona Tavolari, Mariacristina Di Marco et al.
Cancers 2022, 14(10), 2429; https://doi.org/10.3390/cancers14102429
Available online: https://www.mdpi.com/2072-6694/14/10/2429
10. “Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities”
by Carmelo Laface, Palma Fedele, Felicia Maria Maselli, Francesca Ambrogio, Caterina Foti, Pasquale Molinari, Michele Ammendola, Marco Lioce and Girolamo Ranieri
Cancers 2022, 14(16), 4028; https://doi.org/10.3390/cancers14164028
Available online: https://www.mdpi.com/2072-6694/14/16/4028
27 February 2023
Cancers | Top 10 Cited Papers in 2022 in the Section “Molecular Cancer Biology”
1. “Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence”
by Aramini Beatrice, Valentina Masciale, Giulia Grisendi, Federica Bertolini, Michela Maur, Giorgia Guaitoli, Isca Chrystel, Uliano Morandi, Franco Stella, Massimo Dominici et al.
Cancers 2022, 14(4), 976; https://doi.org/10.3390/cancers14040976
Available online: https://www.mdpi.com/2072-6694/14/4/976
2. “CTCF Expression and Dynamic Motif Accessibility Modulates Epithelial–Mesenchymal Gene Expression”
by Kelsey S. Johnson, Shaimaa Hussein, Priyanka Chakraborty, Arvind Muruganantham, Sheridan Mikhail, Giovanny Gonzalez, Shuxuan Song, Mohit Kumar Jolly, Michael J. Toneff, Mary Lauren Benton et al.
Cancers 2022, 14(1), 209; https://doi.org/10.3390/cancers14010209
Available online: https://www.mdpi.com/2072-6694/14/1/209
3. “Antibody–Drug Conjugates as an Emerging Therapy in Oncodermatolog”
by Esnault Clara, David Schrama, Roland Houben, Serge Guyétant, Audrey Desgranges, Camille Martin, Patricia Berthon, Marie-Claude Viaud-Massuard, Antoine Touzé, Thibault Kervarrec et al.
Cancers 2022, 14(3), 778; https://doi.org/10.3390/cancers14030778
Available online: https://www.mdpi.com/2072-6694/14/3/778
4. “Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance”
by Reita Damien, Lucile Pabst, Erwan Pencreach, Eric Guérin, Laurent Dano, Valérie Rimelen, Anne-Claire Voegeli, Laurent Vallat, Céline Mascaux and Michèle Beau-Faller
Cancers 2022, 14(5), 1321; https://doi.org/10.3390/cancers14051321
Available online: https://www.mdpi.com/2072-6694/14/5/1321
5. “Upregulation of CD36, a Fatty Acid Translocase, Promotes Colorectal Cancer Metastasis by Increasing MMP28 and Decreasing E-Cadherin Expression”
by Drury James, Piotr G. Rychahou, Courtney O. Kelson, Mariah E. Geisen, Yuanyuan Wu, Daheng He, Chi Wang, Eun Y. Lee, B. Mark Evers and Yekaterina Y. Zaytseva
Cancers 2022, 14(1), 252; https://doi.org/10.3390/cancers14010252
Available online: https://www.mdpi.com/2072-6694/14/1/252
6. “The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy”
by Canale Matteo, Kalliopi Andrikou, Ilaria Priano, Paola Cravero, Luigi Pasini, Milena Urbini, Angelo Delmonte, Lucio Crinò, Giuseppe Bronte and Paola Ulivi
Cancers 2022, 14(5), 1143; https://doi.org/10.3390/cancers14051143
Available online: https://www.mdpi.com/2072-6694/14/5/1143
7. “High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer”
by Boyaval Fanny, Hans Dalebout, René Van Zeijl, Wenjun Wang, Arantza Fariña-Sarasqueta, Guinevere S. M. Lageveen-Kammeijer, Jurjen J. Boonstra, Liam A. McDonnell, Manfred Wuhrer, Hans Morreau et al.
Cancers 2022, 14(6), 1552; https://doi.org/10.3390/cancers14061552
Available online: https://www.mdpi.com/2072-6694/14/6/1552
8. “Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression”
by Danielle J. Fassler, Luke A. Torre-Healy, Rajarsi Gupta, Alina M. Hamilton, Soma Kobayashi, Sarah C. Van Alsten, Yuwei Zhang, Tahsin Kurc, Richard A. Moffitt, Melissa A. Troester et al.
Cancers 2022, 14(9), 2148; https://doi.org/10.3390/cancers14092148
Available online: https://www.mdpi.com/2072-6694/14/9/2148
9. “Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer”
by Roberto Corchado-Cobos, Natalia García-Sancha, Marina Mendiburu-Eliçabe, Aurora Gómez-Vecino, Alejandro Jiménez-Navas, Manuel Jesús Pérez-Baena, Marina Holgado-Madruga, Jian-Hua Mao, Javier Cañueto, Sonia Castillo-Lluva et al.
Cancers 2022, 14(2), 322; https://doi.org/10.3390/cancers14020322
Available online: https://www.mdpi.com/2072-6694/14/2/322
10. “Circular RNAs Modulate Cancer Hallmark and Molecular Pathways to Support Cancer Progression and Metastasis”
by Aliaksandr A. Yarmishyn, Afeez Adekunle Ishola, Chieh-Yu Chen, Nalini Devi Verusingam, Vimalan Rengganaten, Habeebat Aderonke Mustapha, Hao-Kai Chuang, Yuan-Chi Teng, Van Long Phung, Po-Kuei Hsu et al.
Cancers 2022, 14(4), 862; https://doi.org/10.3390/cancers14040862
Available online: https://www.mdpi.com/2072-6694/14/4/862
27 February 2023
Cancers | Top 10 Cited Papers in 2022 in the Section "Clinical Trials of Cancer"
1. "Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies"
by Md. Sanower Hossain, Hidayah Karuniawati, Ammar Abdulrahman Jairoun, Zannat Urbi, Der Jiun Ooi, Akbar John, Ya Chee Lim, K. M. Kaderi Kibria, A. K. M. Mohiuddin, Long Chiau Ming et al.
Cancers 2022, 14(7), 1732; https://doi.org/10.3390/cancers14071732
Available online: https://www.mdpi.com/2072-6694/14/7/1732
2. "Anaplastic Thyroid Carcinoma: An Update"
by Arnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, Pierre Blanchard, Dana Hartl, Benjamin Chevalier, Frédéric Deschamps, Livia Lamartina, Ludovic Lacroix, Corinne Dupuy et al.
Cancers 2022, 14(4), 1061; https://doi.org/10.3390/cancers14041061
Available online: https://www.mdpi.com/2072-6694/14/4/1061
3. "Current and Developing Liquid Biopsy Techniques for Breast Cancer"
by Hsing-Ju Wu and Pei-Yi Chu
Cancers 2022, 14(9), 2052; https://doi.org/10.3390/cancers14092052
Available online: https://www.mdpi.com/2072-6694/14/9/2052
4. "PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area"
by Antoine Verger, Aurélie Kas, Jacques Darcourt and Eric Guedj
Cancers 2022, 14(5), 1103; https://doi.org/10.3390/cancers14051103
Available online: https://www.mdpi.com/2072-6694/14/5/1103
5. "Phototheranostics of Cervical Neoplasms with Chlorin e6 Photosensitizer"
by Aida Gilyadova, Anton Ishchenko, Artem Shiryaev, Polina Alekseeva, Kanamat Efendiev, Radmila Karpova, Maxim Loshchenov, Victor Loschenov and Igor Reshetov
Cancers 2022, 14(1), 211; https://doi.org/10.3390/cancers14010211
Available online: https://www.mdpi.com/2072-6694/14/1/211
6. "Microwave Ablation for Colorectal Liver Metastases: A Systematic Review and Pooled Oncological Analyses"
by Antonio Mimmo, Francesca Pegoraro, Rami Rhaiem, Roberto Montalti, Alix Donadieu, Ahmad Tashkandi, Abdul Rahman Al-Sadairi, Reza Kianmanesh and Tullio Piardi
Cancers 2022, 14(5), 1305; https://doi.org/10.3390/cancers14051305
Available online: https://www.mdpi.com/2072-6694/14/5/1305
7. "Endocrine and Neuroendocrine Tumors Special Issue—Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work?"
by Camilo Jimenez, Gustavo Armaiz-Pena, Patricia L. M. Dahia, Yang Lu, Rodrigo A. Toledo, Jeena Varghese and Mouhammed Amir Habra
Cancers 2022, 14(3), 467; https://doi.org/10.3390/cancers14030467
Available online: https://www.mdpi.com/2072-6694/14/3/467
8. "Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives"
by Sara Elena Rebuzzi, Pasquale Rescigno, Fabio Catalano, Veronica Mollica, Ursula Maria Vogl, Laura Marandino, Francesco Massari, Ricardo Pereira Mestre, Elisa Zanardi, Alessio Signori et al.
Cancers 2022, 14(5), 1245; https://doi.org/10.3390/cancers14051245
Available online: https://www.mdpi.com/2072-6694/14/5/1245
9. "Application of Artificial Intelligence in Lung Cancer"
by Hwa-Yen Chiu, Heng-Sheng Chao and Yuh-Min Chen
Cancers 2022, 14(6), 1370; https://doi.org/10.3390/cancers14061370
Available online: https://www.mdpi.com/2072-6694/14/6/1370
10. "Prediction of Breast Cancer Histological Outcome by Radiomics and Artificial Intelligence Analysis in Contrast-Enhanced Mammography"
by Antonella Petrillo, Roberta Fusco, Elio Di Bernardo, Teresa Petrosino, Maria Luisa Barretta, Annamaria Porto, Vincenza Granata, Maurizio Di Bonito, Annarita Fanizzi, Raffaella Massafra et al.
Cancers 2022, 14(9), 2132; https://doi.org/10.3390/cancers14092132
Available online: https://www.mdpi.com/2072-6694/14/9/2132
16 February 2023
Increasing Visibility for Preprints.org – Clarivate adds the Preprint Citation Index to the Web of Science

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.
The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.
As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.
MDPI's Preprints Platform – Preprints.org
To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.
During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.
We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.
For more information, please visit Preprints.org.
15 February 2023
Cancers | Top 10 Cited Papers in 2022 in the Section “Cancer Pathophysiology”
1. “Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances”
by Blanca Cucarull, Anna Tutusaus, Patricia Rider, Tania Hernáez-Alsina, Carlos Cuño, Pablo García de Frutos, Anna Colell, Montserrat Marí and Albert Morales
Cancers 2022, 14(3), 621; https://doi.org/10.3390/cancers14030621
Available online: https://www.mdpi.com/2072-6694/14/3/621
2. “The Evolution of Ovarian Carcinoma Subclassification”
by Martin Köbel and Eun Young Kang
Cancers 2022, 14(2), 416; https://doi.org/10.3390/cancers14020416
Available online: https://www.mdpi.com/2072-6694/14/2/416
3. “Chemotherapy Side-Effects: Not All DNA Damage Is Equal”
by Winnie M. C. van den Boogaard, Daphne S. J. Komninos and Wilbert P. Vermeij
Cancers 2022, 14(3), 627; https://doi.org/10.3390/cancers14030627
Available online: https://www.mdpi.com/2072-6694/14/3/627
4. “The Role of Artificial Intelligence in Early Cancer Diagnosis”
by Benjamin Hunter, Sumeet Hindocha and Richard W. Lee
Cancers 2022, 14(6), 1524; https://doi.org/10.3390/cancers14061524
Available online: https://www.mdpi.com/2072-6694/14/6/1524
5. “Energy Sources for Exosome Communication in a Cancer Microenvironment”
by Abhimanyu Thakur, Amanda Johnson, Emily Jacobs, Kui Zhang, Jonathan Chen, Zhubo Wei, Qizhou Lian and Huanhuan Joyce Chen
Cancers 2022, 14(7), 1698; https://doi.org/10.3390/cancers14071698
Available online: https://www.mdpi.com/2072-6694/14/7/1698
6. “Fatty Acid Metabolism in Myeloid-Derived Suppressor Cells and Tumor-Associated Macrophages: Key Factor in Cancer Immune Evasion”
by Sophiya Siddiqui and Rainer Glauben
Cancers 2022, 14(1), 250; https://doi.org/10.3390/cancers14010250
Available online: https://www.mdpi.com/2072-6694/14/1/250
7. “Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer”
by Martín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, Susana Torres-Martínez, Clara García González, José Ángel García García, Vega Iranzo González-Cruz and Carlos Camps Herrero
Cancers 2022, 14(2), 307; https://doi.org/10.3390/cancers14020307
Available online: https://www.mdpi.com/2072-6694/14/2/307
8. “Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers”
by Guillaume Anthony Odri, Joëlle Tchicaya-Bouanga, Diane Ji Yun Yoon and Dominique Modrowski
Cancers 2022, 14(2), 360; https://doi.org/10.3390/cancers14020360
Available online: https://www.mdpi.com/2072-6694/14/2/360
9. “EOB-MR Based Radiomics Analysis to Assess Clinical Outcomes following Liver Resection in Colorectal Liver Metastases”
by Vincenza Granata, Roberta Fusco, Federica De Muzio, Carmen Cutolo, Sergio Venanzio Setola, Federica Dell’Aversana, Alessandro Ottaiano, Guglielmo Nasti, Roberta Grassi, Vincenzo Pilone et al.
Cancers 2022, 14(5), 1239; https://doi.org/10.3390/cancers14051239
Available online: https://www.mdpi.com/2072-6694/14/5/1239
10. “Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma”
by Marco Y. W. Zaki, Ahmed M. Fathi, Samara Samir, Nardeen Eldafashi, Kerolis Y. William, Maiiada Hassan Nazmy, Moustafa Fathy, Upkar S. Gill and Shishir Shetty
Cancers 2022, 14(5), 1255; https://doi.org/10.3390/cancers14051255
Available online: https://www.mdpi.com/2072-6694/14/5/1255